Pharmstandard International S.A.

13F Portfolio Filings

Most recent 13F
Q3 2018
Location
Luxembourg
CIK
0001598762
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2018 7 29,044 ALNAQ, PTGX, NTGN, JNCE 13F-HR 11/15/2018 000095012318012094
Q2 2018 6 24,931 ALNAQ, PTGX, JNCE, PRTO 13F-HR 8/14/2018 000095012318008894
Q1 2018 6 39,810 JNCE, ALNAQ, PTGX, PRTO 13F-HR 5/15/2018 000095012318005814
Q4 2017 6 97,266 ARGS, PTGX, ARGS calls, ALNAQ 13F-HR 2/14/2018 000095012318002251
Q3 2017 5 34,304 PTGX, JNCE, PRTO, ARGS 13F-HR 11/3/2017 000095012317009437
Q2 2017 5 28,842 PTGX, JNCE, ARGS, ARGS calls 13F-HR 8/15/2017 000095012317008099
Q1 2017 5 37,479 JNCE, PTGX, ARGS, ARGS calls RESTATEMENT 8/17/2017 000095012317008128
Q4 2016 4 116,119 ARGS, ARGS calls, PTGX, PRTO 13F-HR 2/14/2017 000095012317001877
Additional filings from Pharmstandard International S.A. that have since been restated